Mutant MHC class II epitopes drive therapeutic immune responses to cancer | Nature
4. Szeged_ENG_web.indd
Máté Manczinger - Junior group leader - HCEMM / Hungarian Centre of Excellence for Molecular Medicine | LinkedIn
Frontiers | From Chickens to Humans: The Importance of Peptide Repertoires for MHC Class I Alleles
Negative trade-off between neoantigen repertoire breadth and the specificity of HLA-I molecules shapes antitumour immunity | bioRxiv
Pathogen diversity drives the evolution of generalist MHC-II alleles in human populations
Proto-oncogene PML controls genes devoted to MHC class I antigen presentation | Nature
Major histocompatibility complex - Wikipedia
Mate Manczinger (@matemanc) / Twitter
![Peptide presentation by HLA-DQ molecules is associated with the development of immune tolerance [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2018/5118/1/fig-1-full.png "Peptide presentation by HLA-DQ molecules is associated with the development of immune tolerance [PeerJ]")
Peptide presentation by HLA-DQ molecules is associated with the development of immune tolerance [PeerJ]
Pathogen diversity drives the evolution of generalist MHC-II alleles in human populations | PLOS Biology
MHC Restriction and the Impact of Self-Recognition on Peripheral T Cell... | Download Scientific Diagram
Major histocompatibility complex - Wikiwand
Pathogen diversity drives the evolution of promiscuous peptide binding of human MHC-II alleles | bioRxiv
Advances in the Evolutionary Understanding of MHC Polymorphism: Trends in Genetics
Major histocompatibility complex - Wikipedia
Mate Manczinger (@matemanc) / Twitter
Cells | Free Full-Text | Avian MHC Evolution in the Era of Genomics: Phase 1.0
Self-mediated positive selection of T cells sets an obstacle to the recognition of nonself | PNAS
Mate Manczinger (@matemanc) / Twitter
Advances in the Evolutionary Understanding of MHC Polymorphism - ScienceDirect
Advances in the Evolutionary Understanding of MHC Polymorphism: Trends in Genetics
Máté Manczinger - Junior group leader - HCEMM / Hungarian Centre of Excellence for Molecular Medicine | LinkedIn
Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitope | Nature Communications
